Toronto, Ontario--(Newsfile Corp. - Le 29 septembre/September 2021) Love Pharma Inc., the issuer resulting from a Fundamental Change of Glenbriar Technologies Inc. (GTI.X), has been approved for listing.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Love Pharma Inc., is a specialized...